Your browser doesn't support javascript.
loading
Effect of weight-adjusted intermediate-dose versus fixed-dose prophylactic anticoagulation with low-molecular-weight heparin on venous thromboembolism among noncritically and critically ill patients with COVID-19: the COVI-DOSE trial, a multicenter, randomised, open-label, phase 4 trial.
Zuily, Stéphane; Lefèvre, Benjamin; Sanchez, Olivier; Empis de Vendin, Ombeline; de Ciancio, Guillaume; Arlet, Jean-Benoît; Khider, Lina; Terriat, Béatrice; Greigert, Hélène; Robert, Céline S; Louis, Guillaume; Trinh-Duc, Albert; Rispal, Patrick; Accassat, Sandrine; Thiery, Guillaume; Montani, David; Azarian, Réza; Meneveau, Nicolas; Soudet, Simon; Le Mao, Raphaël; Maurier, François; Le Moing, Vincent; Quéré, Isabelle; Yelnik, Cécile M; Lefebvre, Nicolas; Martinot, Martin; Delrue, Maxime; Benhamou, Ygal; Parent, Florence; Roy, Pierre-Marie; Presles, Emilie; Goehringer, François; Mismetti, Patrick; Bertoletti, Laurent; Rossignol, Patrick; Couturaud, Francis; Wahl, Denis; Thilly, Nathalie; Laporte, Silvy.
Afiliação
  • Zuily S; Vascular Medicine Division, Université de Lorraine, CHRU-Nancy, Rare Vascular and Systemic Autoimmune Diseases Regional Referral Center, France.
  • Lefèvre B; Inserm, UMR 1116 DCAC, F-54000 Nancy, France.
  • Sanchez O; F-CRIN INNOVTE Network, F-42000 Saint-Etienne, France.
  • Empis de Vendin O; Department of Infectious and Tropical Diseases, Université de Lorraine, CHRU-Nancy, APEMAC, F-54000 Nancy, France.
  • de Ciancio G; Department of Respiratory and Intensive Care Medicine, Université Paris Cité, AP-HP, Hôpital Européen Georges Pompidou, F-75015 Paris, France.
  • Arlet JB; F-CRIN INNOVTE Network, F-42000 Saint-Etienne, France.
  • Khider L; Inserm, Innovative Therapies in Haemostasis, Paris, France.
  • Terriat B; Department of Surgical Intensive Care Unit, CHRU-Nancy, F-54000 Nancy, France.
  • Greigert H; Department of Cardiology, CHRU-Nancy, F-54000 Nancy, France.
  • Robert CS; Internal Medicine Department, AP-HP, Hôpital Européen Georges Pompidou, APHP, F-75015 Paris, France.
  • Louis G; Vascular Medicine Department, Université de Paris, AP-HP, Hôpital Européen Georges Pompidou, F-75015 Paris, France.
  • Trinh-Duc A; Department of Vascular Medicine and Angiology, Dijon University Hospital, F-21000 Dijon, France.
  • Rispal P; Department of Vascular Medicine and Angiology, Dijon University Hospital, F-21000 Dijon, France.
  • Accassat S; Department of Infectious Diseases, CHR Metz-Thionville, F-57000 Metz, France.
  • Thiery G; Intensive Care Unit, CHR Metz-Thionville, F-57000 Metz, France.
  • Montani D; Internal Medicine Department, CH St Esprit, F-47000 Agen, France.
  • Azarian R; Internal Medicine Department, CH St Esprit, F-47000 Agen, France.
  • Meneveau N; Department of Vascular Medicine, CHU Saint-Etienne, F-42000 Saint-Etienne, France.
  • Soudet S; Medical Intensive Care Unit, CHU Saint-Etienne, F-42000 Saint-Etienne, France.
  • Le Mao R; Department of Respiratory and Intensive Care Medicine, Université Paris-Saclay, AP-HP, Hôpital Bicêtre, Pulmonary Hypertension National Referral Center, F-94270 Le Kremlin-Bicêtre, France.
  • Maurier F; Department of Respiratory Medicine, CH Versailles, F-78150 Le Chesnay, France.
  • Le Moing V; Department of Cardiology, Université de Franche-Comté, CHU Jean Minjoz, EA 3929, F-25000 Besancon, France.
  • Quéré I; Department of Vascular Medicine, CHU Amiens-Picardie, F-80000 Amiens, France.
  • Yelnik CM; Department of Internal Medicine, Vascular Medicine and Pulmonology, CHU Brest, F-29200 Brest, France.
  • Lefebvre N; Department of Internal Medicine, UNEOS, F-57070 Metz-Vantoux, France.
  • Martinot M; Department of Infectious and Tropical Diseases, CHRU Montpellier, F-34000 Montpellier, France.
  • Delrue M; Department of Vascular Medicine, CHU Montpellier, IDESP, F-34000 Montpellier, France.
  • Benhamou Y; Department of Internal Medicine and Clinical Immunology, Université de Lille, CHU Lille, Inserm UMR 1167, North and North-West Systemic and Autoimmune Disease National Referral Center (CeRAINO), F-59000 Lille, France.
  • Parent F; Department of Tropical and Infectious Diseases, Hôpitaux Universitaires de Strasbourg, F-67000 Strasbourg, France.
  • Roy PM; Department of Tropical and Infectious Diseases, Hôpitaux Civils de Colmar, F-68000 Colmar, France.
  • Presles E; Hematology Laboratory and Thrombosis Unit, Lariboisière Hospital, APHP, Paris, France.
  • Goehringer F; Department of Internal Medicine, Normandie Université, Université de Rouen Normandie, Inserm UMR 1096, F-76000 Rouen, France.
  • Mismetti P; Department of Respiratory and Intensive Care Medicine, Université Paris-Saclay, AP-HP, Hôpital Bicêtre, Pulmonary Hypertension National Referral Center, F-94270 Le Kremlin-Bicêtre, France.
  • Bertoletti L; Department of Emergency Medicine, Université d'Angers, CHU Angers, F-49000 Angers, France.
  • Rossignol P; Université Jean Monnet, Inserm, U1059 SAINBIOSE, France.
  • Couturaud F; F-CRIN INNOVTE Network, F-42000 Saint-Etienne, France.
  • Wahl D; CHU Saint-Etienne, Unité de Recherche Clinique, Innovation, Pharmacologie, France.
  • Thilly N; Department of Infectious and Tropical Diseases, CHRU-Nancy, F-54000 Nancy, France.
  • Laporte S; Université Jean Monnet, Inserm, U1059 SAINBIOSE, France.
EClinicalMedicine ; 60: 102031, 2023 Jun.
Article em En | MEDLINE | ID: mdl-37350990
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Revista: EClinicalMedicine Ano de publicação: 2023 Tipo de documento: Article País de afiliação: França
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Revista: EClinicalMedicine Ano de publicação: 2023 Tipo de documento: Article País de afiliação: França